This site is intended for healthcare professionals
  • Home
  • /
  • Clinical trials
  • /
  • Natpar
  • /
  • A Open-label Study Investigating the Safety and To...
Clinical trial

A Open-label Study Investigating the Safety and Tolerability of NPSP558, a Recombinant Human Parathyroid Hormone (rhPTH [1-84]), for the Treatment of Adults With Hypoparathyroidism - A Clinical Extension Study (RACE)

Read time: 2 mins
Last updated:1st Apr 2011
Identifier: NCT01297309
Register for free access to this exclusive healthcare learning resource


Why sign up with Medthority?

Develop your knowledge with our disease and condition focused Learning Zones

Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines 

Personalised dashboard providing updates and recommendations for content within your areas of interest